1 Study Coverage 1.1 Dermatology OTC Medications Product Introduction 1.2 Market by Type 1.2.1 Global Dermatology OTC Medications Market Size Growth Rate by Type 1.2.2 External Use 1.2.3 Oral 1.3 Market by Application 1.3.1 Global Dermatology OTC Medications Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Drug Store 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Dermatology OTC Medications Market Size, Estimates and Forecasts 2.1.1 Global Dermatology OTC Medications Revenue 2016-2027 2.1.2 Global Dermatology OTC Medications Sales 2016-2027 2.2 Global Dermatology OTC Medications, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Dermatology OTC Medications Historical Market Size by Region (2016-2021) 2.3.1 Global Dermatology OTC Medications Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Dermatology OTC Medications Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Dermatology OTC Medications Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Dermatology OTC Medications Sales Forecast by Region (2022-2027) 2.4.2 Global Dermatology OTC Medications Revenue Forecast by Region (2022-2027) 3 Global Dermatology OTC Medications Competitor Landscape by Players 3.1 Global Top Dermatology OTC Medications Manufacturers by Sales 3.1.1 Global Dermatology OTC Medications Sales by Manufacturer (2016-2021) 3.1.2 Global Dermatology OTC Medications Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Dermatology OTC Medications Manufacturers by Revenue 3.2.1 Key Dermatology OTC Medications Manufacturers Covered: Ranking by Revenue 3.2.2 Global Dermatology OTC Medications Revenue by Manufacturers (2016-2021) 3.2.3 Global Dermatology OTC Medications Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Dermatology OTC Medications Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Dermatology OTC Medications Revenue in 2020 3.2.6 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Dermatology OTC Medications Price by Manufacturers 3.4 Global Dermatology OTC Medications Manufacturing Base Distribution, Product Types 3.4.1 Dermatology OTC Medications Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Dermatology OTC Medications Product Type 3.4.3 Date of International Manufacturers Enter into Dermatology OTC Medications Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Dermatology OTC Medications Market Size by Type (2016-2021) 4.1.1 Global Dermatology OTC Medications Sales by Type (2016-2021) 4.1.2 Global Dermatology OTC Medications Revenue by Type (2016-2021) 4.1.3 Dermatology OTC Medications Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Dermatology OTC Medications Market Size Forecast by Type (2022-2027) 4.2.1 Global Dermatology OTC Medications Sales Forecast by Type (2022-2027) 4.2.2 Global Dermatology OTC Medications Revenue Forecast by Type (2022-2027) 4.2.3 Dermatology OTC Medications Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Dermatology OTC Medications Market Size by Application (2016-2021) 5.1.1 Global Dermatology OTC Medications Sales by Application (2016-2021) 5.1.2 Global Dermatology OTC Medications Revenue by Application (2016-2021) 5.1.3 Dermatology OTC Medications Price by Application (2016-2021) 5.2 Dermatology OTC Medications Market Size Forecast by Application (2022-2027) 5.2.1 Global Dermatology OTC Medications Sales Forecast by Application (2022-2027) 5.2.2 Global Dermatology OTC Medications Revenue Forecast by Application (2022-2027) 5.2.3 Global Dermatology OTC Medications Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Dermatology OTC Medications Market Size YoY Growth 2016-2027 6.1.1 United States Dermatology OTC Medications Sales YoY Growth 2016-2027 6.1.2 United States Dermatology OTC Medications Revenue YoY Growth 2016-2027 6.1.3 United States Dermatology OTC Medications Market Share in Global Market 2016-2027 6.2 United States Dermatology OTC Medications Market Size by Players (International and Local Players) 6.2.1 United States Top Dermatology OTC Medications Players by Sales (2016-2021) 6.2.2 United States Top Dermatology OTC Medications Players by Revenue (2016-2021) 6.3 United States Dermatology OTC Medications Historic Market Review by Type (2016-2021) 6.3.1 United States Dermatology OTC Medications Sales Market Share by Type (2016-2021) 6.3.2 United States Dermatology OTC Medications Revenue Market Share by Type (2016-2021) 6.3.3 United States Dermatology OTC Medications Price by Type (2016-2021) 6.4 United States Dermatology OTC Medications Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Dermatology OTC Medications Sales Forecast by Type (2022-2027) 6.4.2 United States Dermatology OTC Medications Revenue Forecast by Type (2022-2027) 6.4.3 United States Dermatology OTC Medications Price Forecast by Type (2022-2027) 6.5 United States Dermatology OTC Medications Historic Market Review by Application (2016-2021) 6.5.1 United States Dermatology OTC Medications Sales Market Share by Application (2016-2021) 6.5.2 United States Dermatology OTC Medications Revenue Market Share by Application (2016-2021) 6.5.3 United States Dermatology OTC Medications Price by Application (2016-2021) 6.6 United States Dermatology OTC Medications Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Dermatology OTC Medications Sales Forecast by Application (2022-2027) 6.6.2 United States Dermatology OTC Medications Revenue Forecast by Application (2022-2027) 6.6.3 United States Dermatology OTC Medications Price Forecast by Application (2022-2027) 7 North America 7.1 North America Dermatology OTC Medications Market Size YoY Growth 2016-2027 7.2 North America Dermatology OTC Medications Market Facts & Figures by Country 7.2.1 North America Dermatology OTC Medications Sales by Country (2016-2021) 7.2.2 North America Dermatology OTC Medications Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Dermatology OTC Medications Market Size YoY Growth 2016-2027 8.2 Asia Pacific Dermatology OTC Medications Market Facts & Figures by Region 8.2.1 Asia Pacific Dermatology OTC Medications Sales by Region (2016-2021) 8.2.2 Asia Pacific Dermatology OTC Medications Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Dermatology OTC Medications Market Size YoY Growth 2016-2027 9.2 Europe Dermatology OTC Medications Market Facts & Figures by Country 9.2.1 Europe Dermatology OTC Medications Sales by Country (2016-2021) 9.2.2 Europe Dermatology OTC Medications Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Dermatology OTC Medications Market Size YoY Growth 2016-2027 10.2 Latin America Dermatology OTC Medications Market Facts & Figures by Country 10.2.1 Latin America Dermatology OTC Medications Sales by Country (2016-2021) 10.2.2 Latin America Dermatology OTC Medications Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Dermatology OTC Medications Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Dermatology OTC Medications Market Facts & Figures by Country 11.2.1 Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) 11.2.2 Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Bayer 12.1.1 Bayer Corporation Information 12.1.2 Bayer Description and Business Overview 12.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Bayer Dermatology OTC Medications Products Offered 12.1.5 Bayer Recent Development 12.2 GSK 12.2.1 GSK Corporation Information 12.2.2 GSK Description and Business Overview 12.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.2.4 GSK Dermatology OTC Medications Products Offered 12.2.5 GSK Recent Development 12.3 Teva 12.3.1 Teva Corporation Information 12.3.2 Teva Description and Business Overview 12.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Teva Dermatology OTC Medications Products Offered 12.3.5 Teva Recent Development 12.4 Johnson & Johnson 12.4.1 Johnson & Johnson Corporation Information 12.4.2 Johnson & Johnson Description and Business Overview 12.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered 12.4.5 Johnson & Johnson Recent Development 12.5 Novartis 12.5.1 Novartis Corporation Information 12.5.2 Novartis Description and Business Overview 12.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Novartis Dermatology OTC Medications Products Offered 12.5.5 Novartis Recent Development 12.6 Mylan 12.6.1 Mylan Corporation Information 12.6.2 Mylan Description and Business Overview 12.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Mylan Dermatology OTC Medications Products Offered 12.6.5 Mylan Recent Development 12.7 Sun Pharmaceutical 12.7.1 Sun Pharmaceutical Corporation Information 12.7.2 Sun Pharmaceutical Description and Business Overview 12.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered 12.7.5 Sun Pharmaceutical Recent Development 12.8 Aurobindo 12.8.1 Aurobindo Corporation Information 12.8.2 Aurobindo Description and Business Overview 12.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Aurobindo Dermatology OTC Medications Products Offered 12.8.5 Aurobindo Recent Development 12.9 Galderma 12.9.1 Galderma Corporation Information 12.9.2 Galderma Description and Business Overview 12.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Galderma Dermatology OTC Medications Products Offered 12.9.5 Galderma Recent Development 12.10 CR SANJIU 12.10.1 CR SANJIU Corporation Information 12.10.2 CR SANJIU Description and Business Overview 12.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.10.4 CR SANJIU Dermatology OTC Medications Products Offered 12.10.5 CR SANJIU Recent Development 12.11 Bayer 12.11.1 Bayer Corporation Information 12.11.2 Bayer Description and Business Overview 12.11.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Bayer Dermatology OTC Medications Products Offered 12.11.5 Bayer Recent Development 12.12 Lupin 12.12.1 Lupin Corporation Information 12.12.2 Lupin Description and Business Overview 12.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Lupin Products Offered 12.12.5 Lupin Recent Development 12.13 Bausch Health 12.13.1 Bausch Health Corporation Information 12.13.2 Bausch Health Description and Business Overview 12.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Bausch Health Products Offered 12.13.5 Bausch Health Recent Development 12.14 Cipla 12.14.1 Cipla Corporation Information 12.14.2 Cipla Description and Business Overview 12.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Cipla Products Offered 12.14.5 Cipla Recent Development 12.15 Qilu Pharmaceutical 12.15.1 Qilu Pharmaceutical Corporation Information 12.15.2 Qilu Pharmaceutical Description and Business Overview 12.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Qilu Pharmaceutical Products Offered 12.15.5 Qilu Pharmaceutical Recent Development 12.16 Almirall 12.16.1 Almirall Corporation Information 12.16.2 Almirall Description and Business Overview 12.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Almirall Products Offered 12.16.5 Almirall Recent Development 12.17 Lingrui 12.17.1 Lingrui Corporation Information 12.17.2 Lingrui Description and Business Overview 12.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Lingrui Products Offered 12.17.5 Lingrui Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Dermatology OTC Medications Industry Trends 13.2 Dermatology OTC Medications Market Drivers 13.3 Dermatology OTC Medications Market Challenges 13.4 Dermatology OTC Medications Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Dermatology OTC Medications Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Dermatology OTC Medications Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of External Use Table 3. Major Manufacturers of Oral Table 4. Global Dermatology OTC Medications Market Size Growth Rate by Application (2021-2027) & (M Units) Table 5. Global Dermatology OTC Medications Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Dermatology OTC Medications Sales by Regions (2016-2021) & (M Units) Table 7. Global Dermatology OTC Medications Sales Market Share by Regions (2016-2021) Table 8. Global Dermatology OTC Medications Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Dermatology OTC Medications Sales Forecast by Region (2022-2027) & (M Units) Table 10. Global Dermatology OTC Medications Sales Market Share Forecast by Region (2022-2027) Table 11. Global Dermatology OTC Medications Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Dermatology OTC Medications Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Dermatology OTC Medications Sales by Manufacturers (2016-2021) (M Units) Table 14. Global Dermatology OTC Medications Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Dermatology OTC Medications Manufacturers by Revenue (US$ Million) in 2020 Table 16. Dermatology OTC Medications Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Dermatology OTC Medications Revenue Share by Manufacturers (2016-2021) Table 18. Global Dermatology OTC Medications Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Medications as of 2020) Table 20. Key Manufacturers Dermatology OTC Medications Price (2016-2021) (USD/Unit) Table 21. Dermatology OTC Medications Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Dermatology OTC Medications Product Type Table 23. Date of International Manufacturers Enter into Dermatology OTC Medications Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Dermatology OTC Medications Sales by Type (2016-2021) (M Units) Table 26. Global Dermatology OTC Medications Sales Share by Type (2016-2021) Table 27. Global Dermatology OTC Medications Revenue by Type (2016-2021) (US$ Million) Table 28. Global Dermatology OTC Medications Revenue Share by Type (2016-2021) Table 29. Dermatology OTC Medications Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 30. Global Dermatology OTC Medications Sales Forecast by Type (2022-2027) & (M Units) Table 31. Global Dermatology OTC Medications Sales Market Share Forecast by Type (2022-2027) Table 32. Global Dermatology OTC Medications Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Dermatology OTC Medications Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Dermatology OTC Medications Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 35. Global Dermatology OTC Medications Sales by Application (2016-2021) (M Units) Table 36. Global Dermatology OTC Medications Sales Share by Application (2016-2021) Table 37. Global Dermatology OTC Medications Revenue by Application (2016-2021) (US$ Million) Table 38. Global Dermatology OTC Medications Revenue Share by Application (2016-2021) Table 39. Dermatology OTC Medications Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 40. Global Dermatology OTC Medications Sales Forecast by Application (2022-2027) & (M Units) Table 41. Global Dermatology OTC Medications Sales Market Share Forecast by Application (2022-2027) Table 42. Global Dermatology OTC Medications Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Dermatology OTC Medications Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Dermatology OTC Medications Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 45. United States Dermatology OTC Medications Sales (M Units) of Key Companies (2016-2021) Table 46. United States Dermatology OTC Medications Sales Share by Company (2016-2021) Table 47. United States Dermatology OTC Medications Revenue (US$ Million) by Company (2016-2021) Table 48. United States Dermatology OTC Medications Revenue Share by Company (2016-2021) Table 49. United States Dermatology OTC Medications Sales (M Units) by Type (2016-2021) Table 50. United States Dermatology OTC Medications Sales Share by Type (2016-2021) Table 51. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. United States Dermatology OTC Medications Price (USD/Unit) by Type (2016-2021) Table 53. United States Dermatology OTC Medications Sales (M Units) by Type (2022-2027) Table 54. United States Dermatology OTC Medications Sales Share by Type (2022-2027) Table 55. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. United States Dermatology OTC Medications Revenue Share by Type (2022-2027) Table 57. United States Dermatology OTC Medications Price (USD/Unit) by Type (2022-2027) Table 58. United States Dermatology OTC Medications Sales (M Units) by Application (2016-2021) Table 59. United States Dermatology OTC Medications Sales Share by Application (2016-2021) Table 60. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. United States Dermatology OTC Medications Price (USD/Unit) by Application (2016-2021) Table 62. United States Dermatology OTC Medications Sales (M Units) by Application (2022-2027) Table 63. United States Dermatology OTC Medications Sales Share by Application (2022-2027) Table 64. United States Dermatology OTC Medications Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. United States Dermatology OTC Medications Revenue Share by Application (2022-2027) Table 66. United States Dermatology OTC Medications Price (USD/Unit) by Application (2022-2027) Table 67. North America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 68. North America Dermatology OTC Medications Sales Market Share by Country (2016-2021) Table 69. North America Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Dermatology OTC Medications Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Dermatology OTC Medications Sales by Region (2016-2021) & (M Units) Table 72. Asia Pacific Dermatology OTC Medications Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Dermatology OTC Medications Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Dermatology OTC Medications Revenue Market Share by Region (2016-2021) Table 75. Europe Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 76. Europe Dermatology OTC Medications Sales Market Share by Country (2016-2021) Table 77. Europe Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Dermatology OTC Medications Revenue Market Share by Country (2016-2021) Table 79. Latin America Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 80. Latin America Dermatology OTC Medications Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Dermatology OTC Medications Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Dermatology OTC Medications Sales by Country (2016-2021) & (M Units) Table 84. Middle East and Africa Dermatology OTC Medications Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Dermatology OTC Medications Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country (2016-2021) Table 87. Bayer Corporation Information Table 88. Bayer Description and Business Overview Table 89. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 90. Bayer Dermatology OTC Medications Product Table 91. Bayer Recent Development Table 92. GSK Corporation Information Table 93. GSK Description and Business Overview Table 94. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 95. GSK Product Table 96. GSK Recent Development Table 97. Teva Corporation Information Table 98. Teva Description and Business Overview Table 99. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 100. Teva Product Table 101. Teva Recent Development Table 102. Johnson & Johnson Corporation Information Table 103. Johnson & Johnson Description and Business Overview Table 104. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 105. Johnson & Johnson Product Table 106. Johnson & Johnson Recent Development Table 107. Novartis Corporation Information Table 108. Novartis Description and Business Overview Table 109. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 110. Novartis Product Table 111. Novartis Recent Development Table 112. Mylan Corporation Information Table 113. Mylan Description and Business Overview Table 114. Mylan Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 115. Mylan Product Table 116. Mylan Recent Development Table 117. Sun Pharmaceutical Corporation Information Table 118. Sun Pharmaceutical Description and Business Overview Table 119. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 120. Sun Pharmaceutical Product Table 121. Sun Pharmaceutical Recent Development Table 122. Aurobindo Corporation Information Table 123. Aurobindo Description and Business Overview Table 124. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 125. Aurobindo Product Table 126. Aurobindo Recent Development Table 127. Galderma Corporation Information Table 128. Galderma Description and Business Overview Table 129. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 130. Galderma Product Table 131. Galderma Recent Development Table 132. CR SANJIU Corporation Information Table 133. CR SANJIU Description and Business Overview Table 134. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 135. CR SANJIU Product Table 136. CR SANJIU Recent Development Table 137. Dr. Reddy's Corporation Information Table 138. Dr. Reddy's Description and Business Overview Table 139. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 140. Dr. Reddy's Product Table 141. Dr. Reddy's Recent Development Table 142. Lupin Corporation Information Table 143. Lupin Description and Business Overview Table 144. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 145. Lupin Product Table 146. Lupin Recent Development Table 147. Bausch Health Corporation Information Table 148. Bausch Health Description and Business Overview Table 149. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 150. Bausch Health Product Table 151. Bausch Health Recent Development Table 152. Cipla Corporation Information Table 153. Cipla Description and Business Overview Table 154. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 155. Cipla Product Table 156. Cipla Recent Development Table 157. Qilu Pharmaceutical Corporation Information Table 158. Qilu Pharmaceutical Description and Business Overview Table 159. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 160. Qilu Pharmaceutical Product Table 161. Qilu Pharmaceutical Recent Development Table 162. Almirall Corporation Information Table 163. Almirall Description and Business Overview Table 164. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 165. Almirall Product Table 166. Almirall Recent Development Table 167. Lingrui Corporation Information Table 168. Lingrui Description and Business Overview Table 169. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 170. Lingrui Product Table 171. Lingrui Recent Development Table 172. Dermatology OTC Medications Market Trends Table 173. Dermatology OTC Medications Market Drivers Table 174. Dermatology OTC Medications Market Challenges Table 175. Dermatology OTC Medications Market Restraints Table 176. Dermatology OTC Medications Customers List Table 177. Dermatology OTC Medications Distributors List Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Dermatology OTC Medications Product Picture Figure 2. Global Dermatology OTC Medications Sales Market Share by Type in 2020 & 2027 Figure 3. External Use Product Picture Figure 4. Oral Product Picture Figure 5. Global Dermatology OTC Medications Sales Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Drug Store Figure 8. Other Figure 9. Dermatology OTC Medications Report Years Considered Figure 10. Global Dermatology OTC Medications Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Dermatology OTC Medications Market Size 2016-2027 (US$ Million) Figure 12. Global Dermatology OTC Medications Sales 2016-2027 (M Units) Figure 13. Global Dermatology OTC Medications Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Dermatology OTC Medications Sales Market Share by Region (2016-2021) Figure 15. Global Dermatology OTC Medications Sales Market Share by Region in 2020 Figure 16. Global Dermatology OTC Medications Revenue Market Share by Region (2016-2021) Figure 17. Global Dermatology OTC Medications Revenue Market Share by Region in 2020 Figure 18. Global Dermatology OTC Medications Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Dermatology OTC Medications Revenue in 2020 Figure 20. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Dermatology OTC Medications Sales Market Share by Type (2016-2021) Figure 22. Global Dermatology OTC Medications Sales Market Share by Type in 2020 Figure 23. Global Dermatology OTC Medications Revenue Market Share by Type (2016-2021) Figure 24. Global Dermatology OTC Medications Revenue Market Share by Type in 2020 Figure 25. Global Dermatology OTC Medications Sales Market Share by Application (2016-2021) Figure 26. Global Dermatology OTC Medications Sales Market Share by Application in 2020 Figure 27. Global Dermatology OTC Medications Revenue Market Share by Application (2016-2021) Figure 28. Global Dermatology OTC Medications Revenue Market Share by Application in 2020 Figure 29. United States Dermatology OTC Medications Sales Growth Rate 2016-2027 (M Units) Figure 30. United States Dermatology OTC Medications Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. United States Dermatology OTC Medications Market Share in Global Market 2016-2027 Figure 32. United States 5 and 10 Largest Dermatology OTC Medications Players Market Share by Revenue in Dermatology OTC Medications in 2020 Figure 33. United States Dermatology OTC Medications Revenue Share by Type (2016-2021) Figure 34. United States Dermatology OTC Medications Revenue Growth Rate by Type in 2016 & 2020 Figure 35. United States Dermatology OTC Medications Revenue Share by Application (2016-2021) Figure 36. United States Dermatology OTC Medications Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units) Figure 38. North America Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Dermatology OTC Medications Sales Market Share by Country in 2020 Figure 40. North America Dermatology OTC Medications Revenue Market Share by Country in 2020 Figure 41. U.S. Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 42. U.S. Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 44. Canada Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units) Figure 46. Europe Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Dermatology OTC Medications Sales Market Share by Country in 2020 Figure 48. Europe Dermatology OTC Medications Revenue Market Share by Country in 2020 Figure 49. Germany Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 50. Germany Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 52. France Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 54. U.K. Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 56. Italy Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 58. Russia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units) Figure 60. Asia Pacific Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Dermatology OTC Medications Sales Market Share by Region in 2020 Figure 62. Asia Pacific Dermatology OTC Medications Revenue Market Share by Region in 2020 Figure 63. China Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 64. China Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 66. Japan Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 68. South Korea Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 70. India Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 72. Australia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 74. Taiwan Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 76. Indonesia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 78. Thailand Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 80. Malaysia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 82. Philippines Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 84. Vietnam Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units) Figure 86. Latin America Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Dermatology OTC Medications Sales Market Share by Country in 2020 Figure 88. Latin America Dermatology OTC Medications Revenue Market Share by Country in 2020 Figure 89. Mexico Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 90. Mexico Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 92. Brazil Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 94. Argentina Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Dermatology OTC Medications Sales Growth Rate 2016-2021 (M Units) Figure 96. Middle East and Africa Dermatology OTC Medications Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Dermatology OTC Medications Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country in 2020 Figure 99. Turkey Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 100. Turkey Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 102. Saudi Arabia Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Dermatology OTC Medications Sales Growth Rate (2016-2021) (M Units) Figure 104. UAE Dermatology OTC Medications Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Dermatology OTC Medications Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Bayer GSK Teva Johnson & Johnson Novartis Mylan Sun Pharmaceutical Aurobindo Galderma CR SANJIU Dr. Reddy's Lupin Bausch Health Cipla Qilu Pharmaceutical Almirall Lingrui